Global Patient Derived Xenograft/PDX Models Market Research Report 2019 by Manufacturers, Regions, Types and Applications
Table of Contents
1 Report Overview
- 1.1 Definition
- 1.2 Manufacturers and Regions Overview
- 1.2.1 Manufacturers Overview
- 1.2.2 Regions Overview
- 1.3 Type Overview
- 1.4 Application Overview
- 1.5 Industrial Chain
- 1.5.1 Patient Derived Xenograft/PDX Models Overall Industrial Chain
- 1.5.2 Upstream
- 1.5.3 Downstream
- 1.5.4 Economic/Political Environment
2 Global Patient Derived Xenograft/PDX Models Market Assesment by Types
- 2.1 Overall Market Performance
- 2.1.1 Product Type Market Performance (Volume)
- 2.1.2 Product Type Market Performance (Value)
- 2.2 China Patient Derived Xenograft/PDX Models Market Performance
- 2.3 USA Patient Derived Xenograft/PDX Models Market Performance
- 2.4 Europe Patient Derived Xenograft/PDX Models Market Performance
- 2.5 Japan Patient Derived Xenograft/PDX Models Market Performance
- 2.6 Korea Patient Derived Xenograft/PDX Models Market Performance
- 2.7 India Patient Derived Xenograft/PDX Models Market Performance
- 2.8 Southeast Asia Patient Derived Xenograft/PDX Models Market Performance
- 2.9 South America Patient Derived Xenograft/PDX Models Market Performance
3 Global Patient Derived Xenograft/PDX Models Market Assesment by Application
- 3.1 Overall Market Performance (Volume)
- 3.2 China Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.3 USA Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.4 Europe Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.5 Japan Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.6 Korea Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.7 India Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.8 Southeast Asia Patient Derived Xenograft/PDX Models Market Performance (Volume)
- 3.9 South America Patient Derived Xenograft/PDX Models Market Performance (Volume)
4 Competitive Analysis
- 4.1 Crown Bioscience Inc.
- 4.1.1 Crown Bioscience Inc. Profiles
- 4.1.2 Crown Bioscience Inc. Product Information
- 4.1.3 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.1.4 Crown Bioscience Inc. Patient Derived Xenograft/PDX Models Business Performance
- 4.1.5 SWOT Analysis
- 4.2 the Jackson Laboratory
- 4.2.1 the Jackson Laboratory Profiles
- 4.2.2 the Jackson Laboratory Product Information
- 4.2.3 the Jackson Laboratory Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.2.4 the Jackson Laboratory Patient Derived Xenograft/PDX Models Business Performance
- 4.2.5 SWOT Analysis
- 4.3 Champions Oncology, Inc.
- 4.3.1 Champions Oncology, Inc. Profiles
- 4.3.2 Champions Oncology, Inc. Product Information
- 4.3.3 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.3.4 Champions Oncology, Inc. Patient Derived Xenograft/PDX Models Business Performance
- 4.3.5 SWOT Analysis
- 4.4 Charles River Laboratories International, Inc.
- 4.4.1 Charles River Laboratories International, Inc. Profiles
- 4.4.2 Charles River Laboratories International, Inc. Product Information
- 4.4.3 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.4.4 Charles River Laboratories International, Inc. Patient Derived Xenograft/PDX Models Business Performance
- 4.4.5 SWOT Analysis
- 4.5 WuXi Apptec
- 4.5.1 WuXi Apptec Profiles
- 4.5.2 WuXi Apptec Product Information
- 4.5.3 WuXi Apptec Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.5.4 WuXi Apptec Patient Derived Xenograft/PDX Models Business Performance
- 4.5.5 SWOT Analysis
- 4.6 ONCODESIGN
- 4.6.1 ONCODESIGN Profiles
- 4.6.2 ONCODESIGN Product Information
- 4.6.3 ONCODESIGN Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.6.4 ONCODESIGN Patient Derived Xenograft/PDX Models Business Performance
- 4.6.5 SWOT Analysis
- 4.7 Horizon Discovery Group PLC
- 4.7.1 Horizon Discovery Group PLC Profiles
- 4.7.2 Horizon Discovery Group PLC Product Information
- 4.7.3 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.7.4 Horizon Discovery Group PLC Patient Derived Xenograft/PDX Models Business Performance
- 4.7.5 SWOT Analysis
- 4.8 Pharmatest Services Ltd.
- 4.8.1 Pharmatest Services Ltd. Profiles
- 4.8.2 Pharmatest Services Ltd. Product Information
- 4.8.3 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.8.4 Pharmatest Services Ltd. Patient Derived Xenograft/PDX Models Business Performance
- 4.8.5 SWOT Analysis
- 4.9 Hera Biolabs
- 4.9.1 Hera Biolabs Profiles
- 4.9.2 Hera Biolabs Product Information
- 4.9.3 Hera Biolabs Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.9.4 Hera Biolabs Patient Derived Xenograft/PDX Models Business Performance
- 4.9.5 SWOT Analysis
- 4.10 EPO Berlin-Buch GmbH
- 4.10.1 EPO Berlin-Buch GmbH Profiles
- 4.10.2 EPO Berlin-Buch GmbH Product Information
- 4.10.3 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Production, Revenue, Price and Gross Margin
- 4.10.4 EPO Berlin-Buch GmbH Patient Derived Xenograft/PDX Models Business Performance
- 4.10.5 SWOT Analysis
- 4.11 Xentech
- 4.12 Urolead
5 Competitive Landscape
- 5.1 Global Patient Derived Xenograft/PDX Models Production (K Units) and Market Share by Manufacturers (2014-2019)
- 5.2 Global Patient Derived Xenograft/PDX Models Revenue (M USD) and Market Share by Manufacturers (2014-2019)
- 5.3 Global Patient Derived Xenograft/PDX Models Price (USD/Unit) of Manufacturers (2014-2019)
- 5.4 Global Patient Derived Xenograft/PDX Models Gross Margin of Manufacturers (2014-2019)
- 5.5 Market Concentration
6 Global Patient Derived Xenograft/PDX Models Market Assessment by Regions
- 6.1 Global Patient Derived Xenograft/PDX Models Production (K Units) and Market Share by Regions (2014-2019)
- 6.2 Global Patient Derived Xenograft/PDX Models Revenue (M USD) and Market Share by Regions (2014-2019)
- 6.3 Global Patient Derived Xenograft/PDX Models Price (USD/Unit) by Regions (2014-2019)
- 6.4 Global Patient Derived Xenograft/PDX Models Gross Margin by Regions (2014-2019)
7 Patient Derived Xenograft/PDX Models Regional Analysis
- 7.1 China Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.2 USA Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.3 Europe Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.4 Japan Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.5 Korea Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.6 India Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.7 Southeast Asia Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
- 7.8 South America Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate (2014-2019)
8 Global Patient Derived Xenograft/PDX Models Consumption Assessment
- 8.1 Global Patient Derived Xenograft/PDX Models Consumption and Market Share by Regions (2014-2019)
- 8.2 Global Patient Derived Xenograft/PDX Models Consumption Value and Market Share by Regions (2014-2019)
- 8.3 Global Patient Derived Xenograft/PDX Models Average Price (USD/Unit) by Regions (2014-2019)
9 Global Patient Derived Xenograft/PDX Models Sales Assessment by Regions
- 9.1 Global Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.2 China Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.3 USA Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.4 Europe Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.5 Japan Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.6 Korea Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.7 India Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.8 Southeast Asia Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
- 9.9 South America Patient Derived Xenograft/PDX Models Sales and Sales Value (2014-2019)
10 Technology and Cost
- 10.1 Technology
- 10.2 Cost
11 Channel Analysis
- 11.1 Market Channel
- 11.2 Distributors
12 Market Forecast 2020-2025
- 12.1 Production and Revenue Forecast 2020-2025
- 12.1.1 Global Patient Derived Xenograft/PDX Models Production and Revenue by Regions 2020-2025
- 12.1.2 China Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.3 USA Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.4 Europe Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.5 Japan Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.6 Korea Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.7 India Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.8 Southeast Asia Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.1.9 South America Patient Derived Xenograft/PDX Models Production, Revenue and Growth Rate 2020-2025
- 12.2 Sales and Sales Value Forecast 2020-2025
- 12.2.1 Global Patient Derived Xenograft/PDX Models Consumption and Consumption Calue by Regions 2020-2025
- 12.2.2 Global Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.3 China Patient Derived Xenograft/PDX Models Sales, Sales Value and Growth Rate 2020-2025
- 12.2.4 USA Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.5 Europe Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.6 Japan Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.7 Korea Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.8 India Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.9 Southeast Asia Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.2.10 South America Patient Derived Xenograft/PDX Models Sales and Sales Value Forecast 2020-2025
- 12.3 Global Patient Derived Xenograft/PDX Models Production and Revenue Forecast by Type 2020-2025
- 12.3.1 Overall Market Performance
- 12.3.2 Gastrointestinal Tumor Models
- 12.3.3 Gynecological Tumor Models
- 12.3.4 Respiratory Tumor Models
- 12.3.5 Urological Tumor Models
- 12.3.6 Hematological Tumor Models
- 12.3.7 Other Tumor Models
- 12.4 Global Patient Derived Xenograft/PDX Models Sales Forecast by Application 2020-2025
- 12.4.1 Overall Market Performance
- 12.4.2 Preclinical Drug Development and Basic Cancer Research
- 12.4.3 Biomarker Analysis
- 12.5 Global Patient Derived Xenograft/PDX Models Price and Gross Margin Forecast
- 13.5.1 Global Patient Derived Xenograft/PDX Models Averages Price Development Trend Forecast 2020-2025
- 13.5.2 Global Patient Derived Xenograft/PDX Models Gross Margin Development Trend Forecast 2020-2025
13 Conclusion
Geographically, global Patient Derived Xenograft/PDX Models market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Crown Bioscience Inc.
the Jackson Laboratory
Champions Oncology, Inc.
Charles River Laboratories International, Inc.
WuXi Apptec
ONCODESIGN
Horizon Discovery Group PLC
Pharmatest Services Ltd.
Hera Biolabs
EPO Berlin-Buch GmbH
Xentech
Urolead
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
Gastrointestinal Tumor Models
Gynecological Tumor Models
Respiratory Tumor Models
Urological Tumor Models
Hematological Tumor Models
Other Tumor Models
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Patient Derived Xenograft/PDX Models for each application, including
Preclinical Drug Development and Basic Cancer Research
Biomarker Analysis
Production, consumption, revenue, market share and growth rate are the key targets for Patient Derived Xenograft/PDX Models from 2013 to 2024 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.